New concept drug hunts down late-stage prostate cancer

(European Association of Urology) A new class of drug successfully targets treatment-resistant prostate cancers and prolongs the life of patients. The treatment delivers beta radiation directly to tumour cells, is well tolerated by patients and keeps them alive for longer than standard care, found a phase 3 trial to be presented at the European Association of Urology congress, EAU21, today.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news